Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Total 13F shares
-
2,451,254
-
Share change
-
+291,560
-
Total reported value
-
$344,547
-
Price per share
-
$0.14
-
Number of holders
-
10
-
Value change
-
+$40,083
-
Number of buys
-
4
-
Number of sells
-
2
Institutional Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q2 2023
As of 30 Jun 2023,
Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,451,254 shares.
The largest 10 holders included
COWEN AND COMPANY, LLC, Walleye Capital LLC, Ionic Capital Management LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CSS LLC/IL, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ZAZOVE ASSOCIATES LLC, EQUITEC PROPRIETARY MARKETS, LLC, Walleye Trading LLC, and MORGAN STANLEY.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.